Listing Amsterdam Molecular Therapeutics Terminates and Company and its Shares Cease to Exist

page

English

Documents

Lire

Le téléchargement nécessite un accès à la bibliothèque YouScribe Tout savoir sur nos offres

page

English

Ebook

Lire

Le téléchargement nécessite un accès à la bibliothèque YouScribe Tout savoir sur nos offres

Publié par

amsterdam-molecular-therapeutics-amt-b-v

Nombre de lectures

Langue

English

Listing Amsterdam Molecular Therapeutics Terminates and Company and its Shares Cease to Exist PR Newswire AMSTERDAM, November 16, 2012 AMSTERDAM, November 16, 2012

Voir

Publié par

amsterdam-molecular-therapeutics-amt-b-v

Nombre de lectures

Langue

English

Listing Amsterdam Molecular Therapeutics Terminates and Company and its Shares Cease to Exist

PR Newswire AMSTERDAM, November 16, 2012

AMSTERDAM,November 16, 2012/PRNewswire/ --

Amsterdam Molecular Therapeutics (AMT) Holding NV in liquidation (in liquidatie) (Euronext: AMT) announces that during the action period (verzetsperiode) no action (verzet) was instituted against the account and justification (rekening en verantwoording) as prepared and made available for inspection by the liquidators.

In accordance with previous announcements, as of19 November 2012, AMT's shares will be delisted from NYSE Euronext in Amsterdam, with16 November 2012being the last trading date. On19 November 2012, AMT's liquidation shall be finalised and the legal entity AMT shall cease to exist. As a consequence of AMT ceasing to exist, all AMT shares shall also cease to exist on19 November 2012, without any (further) distribution or compensation to their holders. AMT shareholders that hold their AMT shares in book entry form will have their position in AMT shares in their securities account struck and deleted as per19 November 2012. To the extent that AMT shares still may appear in your securities account after19 November 2012, this will be for administrative purposes only, as the AMT shares proper shall then no longer exist.

OnMarch 30, 2012, an extraordinary general meeting of shareholders approved a major corporate restructuring and financing transaction involving the disposal of the Group's entire business and operations to uniQure B.V. and the subsequent dissolution, liquidation and delisting of AMT (in liquidation).

PRN NLD

Voir